Drug recall · March 13, 2013
HEXTEND 6% Hetastarch in Lactated Electrolyte Injection recall
Why: Lack of Assurance of Sterility: There is the potential for the solution to leak from the seal of the fill tube to the bag.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
HEXTEND 6% Hetastarch in Lactated Electrolyte Injection, 500 mL, Rx only , MANUFACTURED AND DISTRIBUTED BY HOSPIRA, INC., LAKE FOREST, IL 60045, NDC 0409-1555-54
- Lots / codes
Lot # 10-199-JT Exp. 10/13
- Quantity
- 11,412 bags
- Company
- Hospira Inc., Lake Forest, IL
- Distribution
- Nationwide
- Initiated
- October 22, 2012 · Voluntary: Firm initiated
- Classified
- March 5, 2013
- Reported
- March 13, 2013
- Ended
- March 31, 2015
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Hetastarch
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.